Mr. Bechtel is retiring from his directorship due to health issues. Mr. Warmenhoven, who will step in immediately, previously served as CEO and executive chairman of the board for NetApp, a Fortune 500 data storage and management firm.
“Mr. Warmenhoven has deep experience in building great companies,” Theranos CEO Elizabeth Holmes said in a statement. “His insights will be extremely useful as we now work to commercialize our miniLab and proprietary software systems.”
The company also plans to dissolve its board of counselors on Jan. 1 to consolidate and streamline its advisory structure. Theranos’ board of directors and a scientific and medical advisory board will remain intact.
More articles on leadership and management:
Ascension CEO to meet with Trump transition team
DeKalb Medical lays off about 60 employees, CEO resigns
Idaho-based St. Luke’s Health System names 3 new board members
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.